Sanara Medtech Inc expected to post a loss of 2 cents a share - Earnings Preview
Sanara Medtech Inc expected to post a loss of 2 cents a share - Earnings Preview
Sanara Medtech Inc SMTI.OQ SMTI.O is expected to show a rise in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2026
The Fort Worth Texas-based company is expected to report a 12.1% increase in revenue to $28.95 million from $25.83 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Sanara Medtech Inc is for a loss of 2 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Sanara Medtech Inc is $35.00, about 2.7% above its last closing price of $34.09
This summary was machine generated August 7 at 17:21 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)